Karim Fizazi, MD, PhD, on Chemotherapy vs Endocrine Therapy: Patient-Reported Outcomes

Posted: Tuesday, February 25, 2020

Karim Fizazi, MD, PhD, of the Institut Gustave Roussy, discusses the side effects associated with two classes of medical treatment for prostate cancer, patient-reported outcomes, and how toxicities differ.